Effects of hydroxysafflor yellow A on the experimental traumatic brain injury in rats

Journal of Asian Natural Products Research

Volumn 12, Issue 3, 2010, Pages 239-247

  Bie, Xiao Dong ^a   Han, Jue ^b   Dai, Hai Bin ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Zhanongkou Community Medical Care Center   (China)

Author keywords

ATPase; Hydroxysafflor yellow A; MMP 9; SOD; T PA; Traumatic brain injury

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM; GELATINASE B; HYDROXYSAFFLOR YELLOW A; MALONALDEHYDE; NEUROPROTECTIVE AGENT; NIMODIPINE; PLASMINOGEN ACTIVATOR INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SAFFLOWER EXTRACT; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CONTUSION; BRAIN DAMAGE; BRAIN LEVEL; BRAIN MITOCHONDRION; BRAIN SIZE; CALCIUM CELL LEVEL; CARTHAMUS; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARIETAL LOBE; PROTEIN EXPRESSION; RAT; SAFFLOWER; TRAUMATIC BRAIN INJURY;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BRAIN; BRAIN INJURIES; CHALCONE; DISEASE MODELS, ANIMAL; MALONDIALDEHYDE; MITOCHONDRIA; MOLECULAR STRUCTURE; NIMODIPINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; QUINONES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE PLASMINOGEN ACTIVATOR;

RATTUS;

EID: 77951442846     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020903510636     Document Type: Article

References (25)

1. H. Wang, J.R. Lynch, P. Song, H.J. Yang, R.B. Yates, B. Mace, D.S. Warner, J.R. Guyton, and D.T. Laskowitz, Exp. Neurol. 206, 59 (2007).
2. E.M. Bulger, A.B. Nathens, F.P. Rivara, M. Moore, E.J. MacKenzie, and G.J. Jurkovich, Crit. Care Med. 30, 1870 (2002).
3. M.H. Biros and W. Heegaard, Curr. Opin. Crit. Care 7, 444 (2001).
4. J.W. Lighthall, C.E. Dixon, and T.E. Anderson, J. Neurotrauma. 6, 83 (1989).
5. N. Marklund, A. Bakshi, D.J. Castelbuono, V. Conte, and T.K. McIntosh, Curr. Pharm. Des. 12, 1645 (2006).
6. T.K. McIntosh, D.H. Smith, D.F. Meaney, M.J. Kotapka, T.A. Gennarelli, and D.I. Graham, Lab. Invest. 74, 315 (1996).
7. M.R. Meselhy, S. Kadota, Y. Momose, N. Hatakeyama, A. Kusai, M. Hattori, and T. Namba, Chem. Pharm. Bull. (Tokyo) 41, 1796 (1993).
8. J. Tian, G. Li, Z. Liu, and F. Fu, Pharmacology 82, 121 (2008).
9. H. Zhu, Z. Wang, C. Ma, J. Tian, F. Fu, C. Li, D. Guo, E. Roeder, and K. Liu, Planta Med. 69, 429 (2003).
10. X. Wei, H. Liu, X. Sun, F. Fu, X. Zhang, J. Wang, J. An, and H. Ding, Neurosci. Lett. 386, 58 (2005).
11. Y.N. Liu, Z.M. Zhou, and P. Chen, Clin. Exp. Pharmacol. Physiol. 35, 211 (2008).
12. H.B. Zhu, L. Zhang, Z.H. Wang, J.W. Tian, F.H. Fu, K. Liu, and C.L. Li, J. Asian Nat. Prod. Res. 7, 607 (2005).
13. J. Tian, F. Fu, M. Geng, Y. Jiang, J. Yang, W. Jiang, C. Wang, and K. Liu, Neurosci. Lett. 374, 92 (2005).
14. J.F. Turrens, Biosci. Rep. 17, 3 (1997).
15. A.J. Kowaltowski and A.E. Vercesi, Free Radic. Biol. Med. 26, 463 (1999).
16. R. Anup, M. Madesh, and K.A. Balasubramanian, Indian J. Biochem. Biophys. 36, 266 (1999).
17. M. Engelke, H. Diehl, and H. Tahti, Pharmacol. Toxicol. 71, 343 (1992).
18. M.P. Blaustein, Am. J. Physiol. 232, C165 (1977).
19. G.A. Cordis, N. Maulik, D. Bagchi, R.M. Engelman, and D.K. Das, J. Chromatogr. 632, 97 (1993).
20. S. Seckin, S. Dogru-Abbasoglu, C. Basaran-Kucukgergin, E. Yavu, U. Cevikbas, G. Aykac-Toker, and M. Uysal, Res. Commun. Mol. Pathol. Pharmacol. 109, 299 (2001).
21. Y.Y. Jang, J.H. Song, Y.K. Shin, E.S. Han, and C.S. Lee, Pharmacol. Res. 42, 361 (2000).
22. Y.H. Wei and H.C. Lee, Exp. Biol. Med. (Maywood) 227, 671 (2002).
23. H.P. Kohler and P.J. Grant, N. Engl. J. Med. 342, 1792 (2000).
24. A. Marmarou, M.A. Foda, W. van den Brink, J. Campbell, H. Kita, and K. Demetriadou, J. Neurosurg. 80, 291 (1994).
25. N. Borges, A. Cerejo, A. Santos, A. Sarmento, and I. Azevedo, Int. J. Neurosci. 114, 217 (2004).